• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Front Med (Lausanne) . Population Genomics Approaches for Genetic Characterization of SARS-CoV-2 Lineages

tetano

Editor, Senior Moderator
Front Med (Lausanne)


. 2022 Feb 21;9:826746.
doi: 10.3389/fmed.2022.826746. eCollection 2022.
Population Genomics Approaches for Genetic Characterization of SARS-CoV-2 Lineages


Fatima Mostefai[SUP] 1 2 [/SUP], Isabel Gamache[SUP] 1 2 [/SUP], Arnaud N'Guessan[SUP] 1 3 [/SUP], Justin Pelletier[SUP] 1 2 [/SUP], Jessie Huang[SUP] 4 [/SUP], Carmen Lia Murall[SUP] 3 [/SUP], Ahmad Pesaranghader[SUP] 5 [/SUP], Vanda Gaonac'h-Lovejoy[SUP] 2 6 [/SUP], David J Hamelin[SUP] 1 2 6 [/SUP], Raphaël Poujol[SUP] 1 [/SUP], Jean-Christophe Grenier[SUP] 1 [/SUP], Martin Smith[SUP] 2 6 [/SUP], Etienne Caron[SUP] 6 7 [/SUP], Morgan Craig[SUP] 6 8 [/SUP], Guy Wolf[SUP] 5 8 [/SUP], Smita Krishnaswamy[SUP] 4 9 [/SUP], B Jesse Shapiro[SUP] 3 [/SUP], Julie G Hussin[SUP] 1 10 [/SUP]



Affiliations

Abstract

The genome of the Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2), the pathogen that causes coronavirus disease 2019 (COVID-19), has been sequenced at an unprecedented scale leading to a tremendous amount of viral genome sequencing data. To assist in tracing infection pathways and design preventive strategies, a deep understanding of the viral genetic diversity landscape is needed. We present here a set of genomic surveillance tools from population genetics which can be used to better understand the evolution of this virus in humans. To illustrate the utility of this toolbox, we detail an in depth analysis of the genetic diversity of SARS-CoV-2 in first year of the COVID-19 pandemic. We analyzed 329,854 high-quality consensus sequences published in the GISAID database during the pre-vaccination phase. We demonstrate that, compared to standard phylogenetic approaches, haplotype networks can be computed efficiently on much larger datasets. This approach enables real-time lineage identification, a clear description of the relationship between variants of concern, and efficient detection of recurrent mutations. Furthermore, time series change of Tajima's D by haplotype provides a powerful metric of lineage expansion. Finally, principal component analysis (PCA) highlights key steps in variant emergence and facilitates the visualization of genomic variation in the context of SARS-CoV-2 diversity. The computational framework presented here is simple to implement and insightful for real-time genomic surveillance of SARS-CoV-2 and could be applied to any pathogen that threatens the health of populations of humans and other organisms.

Keywords: SARS-CoV-2; haplotype network; lineage annotation; population genomics; principal component analysis; variant detection; viral surveillance.
 
Back
Top Bottom